San Antonio Breast Cancer Symposium Presentations Highlight Personalized Cancer Treatment
December 14, 2011
San Antonio Breast Cancer Symposium Presentations Highlight Personalized Cancer Treatment
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PGx Drugs Xalkori, Zelboraf Show Strong Growth in First Quarter of 2013
May 1, 2013 / Pharmacogenomics Reporter - MDx/CDx Focus: Siemens Inks Companion Dx Partnerships; FDA Accepts Roche's Pertuzumab BLA
February 8, 2012 / Pharmacogenomics Reporter - Ventana's Growing Companion Dx Focus Mirrors Parent Roche's Investment in Personalized Rx
January 18, 2012 / Pharmacogenomics Reporter - New VEGF Biomarker Data Illustrates Complexities of Personalizing Anti-Angiogenic Drugs
September 28, 2011 / Pharmacogenomics Reporter - Genentech Study Backs Submission of New Herceptin/Pertuzumab Combo in HER2 Metastatic Breast Cancer
August 10, 2011 / Pharmacogenomics Reporter